Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001372514-25-000026
Filing Date
2025-04-02
Accepted
2025-04-02 20:11:50
Documents
1
Period of Report
2025-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1743639103.html 4  
1 FORM 4 wk-form4_1743639103.xml 4 3947
  Complete submission text file 0001372514-25-000026.txt   5523
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3565 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address
Stengone Carmine N. (Reporting) CIK: 0001861519 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36672 | Film No.: 25807082